We found the specificity of KLK6 to be relatively high (88%) when comparing late stage ovarian cancer to healthy or benign cases; however the sensitivity was much lower (~ 40%) when comparing early stage ovarian cancer to healthy or benign cases. Here, KLK6 is linked to ovarian cancer.